Literature DB >> 8807126

Physical and psychosocial functioning of 117 survivors of bone marrow transplantation.

J M Prieto1, R Saez, E Carreras, J Atala, J Sierra, M Rovira, M Batlle, J Blanch, R Escobar, E Vieta, E Gomez, C Rozman, E Cirera.   

Abstract

All surviving patients receiving a BMT at our center since 1976 were surveyed. Among 163 eligible patients, 145 were contacted and 117 (81%) responded. Their median follow-up was 55 months (range 6-154). The research instruments consisted of a demographic questionnaire, a current medical status form, a quality of life questionnaire (Nottingham Health Profile), and a screening instrument for psychiatric morbidity (the 28-item version of the General Health Questionnaire). Current functioning varied considerably across patients. They reported a high use of medical services (37%) and varied ongoing medical problems within the last 6 months. Most of them (93%) received Karnofsky ratings of 80 or above. Eight percent had current chronic GVHD. Comparing our patients' quality of life with a British reference population, most important differences were found for physical mobility, work, and sex life. Psychiatric morbidity in BMT survivors was higher than in a Spanish general population. Multivariate analyses revealed that a higher systemic symptomatology score, a lower educational level, an older age at BMT, a shorter time post-BMT, a female gender, and impotence were significant predictors of an impaired overall quality of life. Similarly, a higher systemic symptomatology score, a shorter time post-BMT, a higher number of major infections, and a lower educational level were predictive factors of a higher psychosocial distress. No differences in quality of life or psychosocial status between allogeneic and autologous transplants were found. Quality of life and psychosocial distress improved with the passage of time, specially within the first 3 years.

Entities:  

Mesh:

Year:  1996        PMID: 8807126

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  19 in total

1.  Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation.

Authors:  Katherine N DuHamel; Catherine E Mosher; Gary Winkel; Larissa E Labay; Christine Rini; Yeraz Markarian Meschian; Jane Austin; Paul B Greene; Catalina R Lawsin; Anna Rusiewicz; Celia L Grosskreutz; Luis Isola; Craig H Moskowitz; Esperanza B Papadopoulos; Scott Rowley; Eileen Scigliano; Jack E Burkhalter; Karen E Hurley; Andreas R Bollinger; William H Redd
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

Review 2.  Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.

Authors:  Subash C Gupta; Ji Hye Kim; Ramaswamy Kannappan; Simone Reuter; Patrick M Dougherty; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

3.  Factors associated with self-reported physical and mental health after hematopoietic cell transplantation.

Authors:  John R Wingard; I-Chan Huang; Kathleen A Sobocinski; Michael A Andrykowski; David Cella; J Douglas Rizzo; Marianne Brady; Mary M Horowitz; Michelle M Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-01       Impact factor: 5.742

4.  Effect of sertraline on complications and survival after hematopoietic stem-cell transplantation, a double-blind, placebo-controlled clinical study.

Authors:  Maria Tavakoli-Ardakani; Raziyeh Kheshti; Mehrpooya Maryam
Journal:  Int J Hematol       Date:  2017-08-16       Impact factor: 2.490

5.  Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia.

Authors:  S Kurosawa; T Yamaguchi; T Mori; H Kanamori; Y Onishi; N Emi; S Fujisawa; A Kohno; C Nakaseko; B Saito; T Kondo; M Hino; Y Nawa; S Kato; A Hashimoto; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2015-06-15       Impact factor: 5.483

6.  Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: comparison with matched healthy group.

Authors:  Fawwaz Alaloul; Dorothy Y Brockopp; Michael A Andrykowski; Lynne A Hall; Taghreed S Al Nusairat
Journal:  Support Care Cancer       Date:  2015-01-06       Impact factor: 3.603

7.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

8.  Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.

Authors:  F Lennie Wong; Liton Francisco; Kayo Togawa; Alysia Bosworth; Mitzi Gonzales; Cara Hanby; Melanie Sabado; Marcia Grant; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

9.  Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).

Authors:  S A Mitchell; N Kline Leidy; K H Mooney; W N Dudley; S L Beck; P C LaStayo; E W Cowen; P Palit; L E Comis; M C Krumlauf; D N Avila; N Atlam; D H Fowler; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2009-09-28       Impact factor: 5.483

10.  Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.

Authors:  Xin Shelley Wang; Qiuling Shi; Lori A Williams; Charles S Cleeland; Gary M Mobley; James M Reuben; Bang-Ning Lee; Sergio A Giralt
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.